Ewing sarcoma (EwS) is an aggressive childhood malignancy with a high propensity for metastasis. By analyzing cohorts of patients and age-matched healthy donors, we establish that EwS metastatic progression is accompanied by elevated plasma levels of multiple proinflammatory cytokines, interferons and extracellular vesicles (EVs). The latter were enriched with transcripts derived from LINE, SINE and ERV retroelements and from locus-specific pericentromeric regions, including HSAT2. We show that some of these RNAs, including HSAT2 and HERV-K, are selectively transmitted in EwS EVs and taken up by stromal fibroblasts and peripheral blood CD33 + myeloid cells and CD8 + T-cells, inducing immune exhaustion, immunosuppressive phenotypes and proinflammatory responses. Moreover, EwS EV-derived repeat RNAs were propagated and serially transmitted in recipient cell EVs, reminiscent of viral infection. As such, this study uncovers a novel mechanism driving cancer-associated inflammation, immunosuppression and metastatic progression.
BACKGROUND
Although a connection between inflammation and cancer was postulated by Rudolf Virchow more than a century ago 1 , it has only recently been recognized as a critical characteristic underlying tumorigenesis 2 . It is now widely accepted that cytokines, tissue remodeling enzymes, reactive oxygen and nitrogen species and other effectors of inflammation released by immune and stromal cells in the tumor microenvironment support neoplastic progression [1] [2] [3] . Emerging evidence has implicated tumorderived extracellular vesicles (EVs), of which exosomes (~40-150 nm vesicles) are the best studied 4,5 , as additional prominent players in cancer-host crosstalk and cancer-associated inflammation 5, 6 . They do so by transferring tumor-derived antigens and a variety of coding and noncoding RNAs, many of which are capable of activating Toll-and RIG-like pattern recognition receptors and innate immune inflammatory responses in recipient cells [5] [6] [7] . This, in turn, induces expression and secretion of interferons (IFNs) and a variety of proinflammatory proteins, whose sustained production not only fuels tumorigenesis but also provides escape from immune surveillance, causing progressive dysfunction of the immune system 5,8,9 . In particular, inflammatory mediators produced by tumor and stromal cells promote generation and expansion of various immunosuppressive cells of myeloid and lymphoid origin, including myeloid-derived suppressive cells (MDSCs) 5,10-12 , regulatory CD4 + (Tregs), tolerogenic and exhausted CD8 + T-cells 9, 13, 14 . Studying mechanisms of cancer EV-mediated inflammation and immunosuppression may therefore provide means for therapeutically reactivating key components of the immune system, restoring anticancer immunity and improving clinical efficacy of cancer immunotherapy.
Inflammation and immunosuppression may be especially relevant to Ewing sarcoma (EwS), an aggressive childhood cancer of bone and soft tissues characterized by recurrent EWS-ETS gene fusions, scant immune infiltrates and a high propensity for metastasis 15, 16 . It is also associated with systemic inflammation, including elevated white blood cell counts and C-reactive protein levels, each of which is correlated with poor prognosis 17 . Survival of patients with metastatic disease is poor and has not significantly improved over the past 20 years 18, 19 , in spite of high dose therapy and allogeneic stem cell transplantation 20 . Here we describe a role of EwS EVs in transmitting retroelement and pericentromeric RNAs into stromal fibroblasts and immune cells, and in expansion of immunosuppressive CD33 + HLA-DR -, CD33 + CD25 + , CD33 + PD-1 + MDSC-like and CD8 + CD25 + PD-1 + Tcells in peripheral blood of EwS patients. We also provide evidence that recipient cells become secondary transmitters of EwS-derived transcripts, by propagating and further disseminating these species in their own EVs. This phenomenon may underlie the paradoxical co-occurrence of inflammation and immunosuppression observed in EwS and, likely, in a number of other cancers.
RESULTS

Elevated inflammatory plasma proteins in EwS
To characterize systemic inflammation in EwS pathogenesis, we analyzed 33 plasma specimens from 30 EwS patients, 17 of which were from the Technical University München (Germany; TUM cohort) and 13 from the Institut Curie (France; EW cohort). In most cases (23 of 33), blood was drawn at diagnosis prior to chemotherapy (see Extended Data Table 1 ). Using the Bio-Plex profiling platform, we established that levels of 23 of 37 tested proinflammatory proteins were significantly elevated in plasma from EwS patients compared to a control cohort of 14 age-matched non-cancer subjects ( Fig. 1a ;
Extended Data Table 2 ). These included tissue and bone remodeling/osteolytic enzymes such as matrix metalloproteinases (MMP-1, 2 and 3), chitinase 3-like 1 (CHI3L1) and osteopontin (OPN), secreted by tumor and certain activated immune cells, and known to play active roles in tumor invasion and inflammation. Among cytokines upregulated 2-fold or greater in EwS patients, we identified IL-2, -11, - 12 [p40], -32, -35, TSLP and IL-10 family members, including IL-10, -22, -26 ( Fig. 1a; p<0 .0001, t-test).
The upregulated cytokines are involved in host defense against pathogens, but their prolonged expression is associated with metastatic progression, cancer-associated inflammation, immune tolerance and, in the case of IL-2, IL-10 and IL-35, immunosuppression 5, 11, 12 . Also, consistent with sustained inflammation, interferon type I (IFNα and β), type II (IFNγ) and type III (IL-28A/IFNλ2 and IL-29/IFNλ1) were significantly elevated in EwS patients compared to non-cancer subjects ( Fig. 1a; p<0.0001, t-test). Metastatic disease was accompanied by additional increases in OPN, CHI3L1, IL-2, IL-10 and IFNβ levels as well as other potent modulators of the immune response, such as TNFSF13, TNFRSF8, gp130 and IL-8 ( Fig. 1b and Extended Data Table 1 ). Many of these cytokines are upregulated during persistent viral infections and cancer, affecting myeloid cells and T-cells among others 5, 8, 11 . Elevated levels of these proinflammatory proteins in patients with metastasis were independent of other clinical characteristics, such as sex, relapse or chemotherapy (Extended Data   Table 3a ), highlighting their strong association with EwS progression.
Predominance of repeat RNAs in EwS plasma EVs
To investigate if elevated levels of proinflammatory cytokines and IFNs might be linked to circulating EVs in EwS, plasma EVs from healthy donors and EW and TUM patients' cohorts were purified by differential centrifugation (Extended Data Fig. 1a ). Their characteristics were consistent with those of exosomes 21 , including their size (40-150 nm), enrichment with known exosome markers (CD63, CD81, Hsp70 and Hsp90), RNA-binding proteins (EWS, TIAR, hnRNPA/B, nucleolin and snRNA-associated Sm B/B' proteins) and 20-400-nt small RNA species (Extended Data Fig. 1b-h) . Moreover, plasma EV preparations were also similar to those purified from conditioned medium (CM) of EwS cell lines grown under ambient conditions or recovering after a short 30-min exposure to sodium arsenate (SA), a commonly used agent for activation of tumor-associated stress response programs, including oxidative stress 22, 23 . Notably, EVs from SA-treated cells possessed higher levels of RNA-binding proteins and Hsp70 (Extended Data Fig. 1c ), likely reflective of a stress response 22 . Compared to healthy subjects (n=38), plasma EV RNA levels were significantly increased in patients with localized (n=15) and metastatic (n=19) tumors ( Fig. 2a and Extended Data Tables 1, 2), being positively associated with proinflammatory protein levels in EwS patients.
To examine the RNA content, plasma EV RNA preparations from the EW cohort were interrogated using whole transcriptome RNA sequencing (RNAseq). Twelve of fifteen samples in this cohort yielded high-quality RNAseq libraries. Distribution of normalized uniquely mapped non-ribosomal RNAseq reads revealed a high prevalence of exonic non-coding and intergenic RNAs ( Fig. 2b ). Among the most prevalent species was the previously reported 7SL/SRP RNA 24 , a core component of the signal recognition particle, as well as diverse long and short interspersed nuclear elements (LINEs and SINEs), long terminal repeat/ human endogenous retroviruses (LTR/ERVs) and satellite RNAs (Extended Data Table 4 ), many of which were elevated in patients with metastasis, although only satellite transcripts reached statistical significance ( Fig. 2c and Extended Data Fig. 2a ).
While most of the detected repeat-derived EV RNAs had limited or no coding capacity, some are annotated in the genome-based endogenous viral protein-coding elements (gEVE) database 25 . Based on their high coverage with respective RNAseq reads, these RNAs, including ERV1, ERV2/HERV-K and ERV3/ERV-L and LINE-1 (L1), contain extended open reading frames (ORFs) for various retroviral polypeptides with predicted sizes ranging from 10 to more than 100 kDa, including reverse transcriptase (RT), envelop (Env), polymerase (Pol) and L1's ORF1 and ORF2 (Extended Data Table 5a ). Importantly, ERVs with extended ORFs were low or undetectable in plasma EVs from patients with localized disease, while being significantly elevated in those with metastasis (p≤0.0006, Wilcoxon test; Fig. 2d , e).
Likewise, L1 RNAs with long ORFs were significantly elevated in patients with metastasis, with the vast coming from evolutionarily younger subfamilies, including retrotransposition active human-specific L1Hs and primate L1P1, L1PA2-A5 (Extended Data, Fig. 2b-d and Table 5a ). Their actual ability for retrotransposition and the capacity to produce proteins in recipient cells remains to be investigated.
Genome-wide mapping of respective RNAseq reads revealed that L1, SINE, and LTR/ERV
RNAs were derived from multiple intergenic and exonic regions (Extended Data Fig. 2d , Extended Data Table 5a , b, and data not shown), potentially due to widespread epigenetic alterations of cancer genome 26 . In contrast, uniquely mapped satellite repeat reads were primarily derived from the chr2p11.2, 4p11, 10q11.21 and 21p11.2 pericentromeric regions ( Fig. 2f ), originating from simple (CATTC)n and (GAATG)n repeats, mostly located within human satellite HSAT2 and HSAT3 27, 28 . Interestingly, the majority of patients (9 of total 12) were positive for 4p11 transcripts, while RNAs mapped to all four genomic loci were found exclusively in patients with metastasis (3 of 7). These transcripts were present in both sense and antisense orientations (Extended Data Fig. 3a, b ), in line with their bidirectional transcription under various stress conditions, during development, senescence and cancer [29] [30] [31] [32] . Based on read counts, HSAT2 and HERV-K, but not ACRO1 (derived from the chr2p11.2, 4p11 and 21p11.2 regions), were significantly elevated in plasma EVs from patients with metastatic as compared to localized disease (Fig. 2g ), and their increase was independent of other clinical parameters (Extended Data Table 3b ).
These results were validated by droplet-based digital PCR (ddPCR), using an independent set of 20 plasma EV RNA preparations (representing 17 different TUM patients; Extended Data Table 1) and 49 age-matched non-cancer patients (Extended Data Table 2 ). We found that all three tested RNAs, ACRO1, HSAT2 and HERV-Kenv (detected using primers to the relatively conserved region of the envelope gene), were significantly elevated in EwS patients compared to healthy donors ( Fig. 2h ).
Therefore, retroelement and pericentromeric RNAs are abundant in exosome-like plasma EV particles of EwS patients, and many of them are increased with metastatic progression. Table 5b ), suggesting that their release or stability in EVs are reduced under oxidative stress conditions.
Selective release of repeat RNAs in EVs
Remarkably, EVs isolated from TC32 cells (but not from A4573 or TC71 cells) exhibited patterns of locus-specific pericentromeric transcripts similar to those of plasma EVs from patients with metastasis, with (CATTC)n, (GAATG)n and HSAT2 RNAseq reads constituting up to 40% of all satellite reads in EVs from mock-and even higher from SA-treated cells, compared to less than 2% of these reads detected in respective TC32 cells (Extended Data Fig. 6a, b ). Furthermore, TC32 EVs contained equal amounts of sense and antisense HSAT transcripts, presumably in a form of double-stranded RNAs (Jaccard coeff. ~0.5), while only sense RNAs were detected in TC32 cells (Jaccard coeff. ~0; Extended Data Fig. 6c ), suggesting strand-specificity of their retention and release. Therefore, in contrast to L1
and ERVs which were detected in all three EwS cell lines and in their EVs, HSAT2 RNAs were expressed in only one of three EwS cell lines and preferentially released in EVs, with only a small proportion of sense transcripts retained in tumor cells, arguing for a distinct role of HSAT2 in EwS tumorigenesis.
EwS EVs target CD33 + myeloid cells and CD8 + T-cells
Repeat RNA-enriched plasma EVs could originate from tumor cells, as suggested by their similarity to those purified from EwS cell lines, or, alternatively, from tumor-educated platelets or immune cells 4,6,9 . To investigate, we employed PrimeFlow RNA assay which allows for simultaneous detection of a particular cell (based on the respective cell surface protein markers) and RNA molecules it carries.
Analysis of peripheral blood mononuclear cells (PBMCs) purified from 8 healthy donors and 12 EwS patients whose plasma EVs were positive for HSAT2 and HERV-Kenv (see Extended Data Table 1) revealed two HERV-Kpol and HSAT2-positive populations, CD45 + CD33 + myeloid and CD45 + CD3 + CD8 + T-cells, in patient-derived PBMCs (Fig. 3a , top panels). The largest population, CD45 + CD33 + cells (composed of early myeloid progenitors, monocytes and MDSCs) 10, 33 , exhibited a greater than 10-fold increase in these transcripts compared to healthy donors (p<0.0005, Wilcoxon test). Meanwhile, CD45 + CD3 + CD4 + T-cells and CD45 + CD19 + B-cells were consistently negative ( To further characterize HERV-Kpol and HSAT2-positive populations, we employed HLA-DR (differentiation marker, to distinguish between more differentiated HLA-DR + myeloid cells and HLA-DR -MDSCs) 11, 33 , CD25 (CD8 + T-cell activation marker; also associated with MDSCs or with immunosuppressive regulatory CD4 + and CD8 + T-cells) 12, 14 and PD-1, one of the best characterized markers of tolerance, immunosuppression and CD8 + T-cell exhaustion 13, 14 . Analysis of PBMCs from an additional 5 patients (all with localized tumors; pre-treatment) and 5 healthy donors identified the largest subsets positive for both HERV-Kpol and HSAT2, including CD33 + HLA-DR -(early-stage MDSCs 33 ), CD33 + PD-1 + and CD33 + CD25 + MDSC-like cells, and CD8 + CD25 + PD-1 + T-cells with exhaustionassociated phenotype 13, 14, 35 (Fig. 3b , top panels). In the majority of CD33 + subsets, levels of both HERV-Kpol and HSAT2 were significantly increased in EwS patients compared to healthy donors (p<0.005, Wilcoxon test), indicating their causative association with EwS. Surprisingly however, the CD8 + subsets, such as HSAT2-positive CD25 -PD-1 + and CD25 + PD-1as well as CD25 + PD-1 + (positive for both HSAT2 and HERV-Kpol), were also identified in healthy donors (Fig. 3b , top panels), likely reflecting their involvement in surveillance or tolerance to self-antigens 35 . These subsets, however, were significantly expanded in EwS patients, representing only ~1-2% of total CD8 + T-cell population in healthy donors and up to 15% in patients (p<0.005, Wilcoxon test; Fig. 3b , bottom panels). Likewise, the CD33 + HSAT2
and HERV-Kpol-positive subsets were increased by ~3-5 fold in EwS patients, while their counterpart populations were decreased (p<0.005, Wilcoxon test; Fig. 3b , bottom panels), indicating that expansion of these MDSC-like subsets could be due to altered differentiation of immature CD33 + myeloid cells.
To test if HERV-K and HSAT2 positivity was the result of EwS EV uptake, healthy donor PBMCs were treated for 48 h with EVs from (i) A4573, A673, TC32 or TC71 cell lines, or from plasma of (ii) healthy donors or (iii) EwS patients. Compared to healthy donor EVs, treatment with EVs from EwS cell lines or patients plasma increased HERV-K and HSAT2 levels in CD33 + cells by 20-and 40-fold, respectively, (p<0.05, Wilcoxon test; Fig. 3c ), revealing these cells as a major target population. Similar to patients' blood, CD8 + cells were the second largest affected population; however, it remains to be established if they acquire EwS EV-derived RNAs directly or via contact with the "infected" CD33 + antigen presenting cells. For unclear reasons, in in vitro settings, transfer of HSAT2 was more efficient than that of HERV-K and was also observed in CD4 + T-cells and CD19 + B-cells ( Fig. 3c ).
To further examine the functional relevance of these findings, we employed MUTZ-3, an early progenitor myeloid cell line capable of differentiating into dendritic cells (DCs) when exposed to GM-CSF, IL-4 and TNFα 36 . We found that treatment with TC32 EVs accelerated their differentiation, including formation of cytoplasmic protrusions and elevated expression of DC-LAMP/CD208 (Extended Data Fig.   7a ). However, we also observed upregulation of immunosuppressive molecules commonly produced by MDSCs in a variety of cancers 11, 12, 37 , including indoleamine 2,3 deoxygenase (IDO1) and transforming growth factor β (TGFβ; Extended Data Fig. 7a ). Moreover, treatment of MUTZ-3 or HL-60 progenitor cells with EVs from A4573, TC32 or TC71 cells induced secretion of the immunosuppressive cytokines IL-10 and IL-35, along with a multitude of other proinflammatory proteins and IFNs, many of which were also elevated in plasma of EwS patients (Extended Data Fig. 7b , c, compare to Fig 1a) , and may contribute to the development of functionally impaired myeloid and T-cell subtypes 12, 14, 37 . This data implicates EwS EVs in acquisition of inflammatory and immunosuppressive phenotypes by immature CD33 + myeloid cells and CD8 + T-cells, in part due to the uptake of EwS-derived repeat RNAs, including HERV-K and HSAT2.
EwS EV RNAs are transmitted into stromal cells in vivo
To investigate if EwS EV RNAs could also be transmitted into stromal cells of the tumor microenvironment, TC32 EwS cells were implanted under the renal capsules of NOD/SCID mice, as previously described 38 . Tumor xenografts exhibited uniform sheets of small round blue cells with enlarged nuclei and minimal cytoplasm ( Fig. 4a , top), characteristic of EwS 15 . ViewRNA in situ hybridization (ViewRNA ISH) showed that both HSAT2 and HERV-Kpol were co-localized and detected in nuclei of the majority of xenografted TC32 cells (Fig. 4a, bottom) . Testing for HSAT2 in combination with probes for mouse Cd45 or Fsp-1/S100a4, markers of immune cells and fibroblasts, respectively, revealed that more than 20% of tumor-infiltrating mouse Cd45 + and Fsp-1 + cells were also positive for human-specific HSAT2 (Fig. 4b) , consistent with EV-mediated transfer from tumor cells. Neither normal human kidney tissue (Extended Data Fig. 8a ) nor adjacent mouse renal epithelial cells (see asterisks in 
Cell-to-cell transmission of EwS EV RNAs
To further examine mechanisms driving inflammation and EwS EV RNA dissemination in the tumor microenvironment, we used MRC5 non-transformed lung fibroblasts. Treatment of these cells with TC32 EVs or mock controls for 6 h, followed by Bio-Plex 37-plex cytokine profiling of CM collected 18 h later, confirmed activation of an antiviral response, as shown by elevation of type I and type III IFNs above a 2-fold threshold ( Fig. 5a ). Whole transcriptome RNAseq then revealed the appearance of TC32 EV-like patterns of locus-specific pericentromeric RNA expression in recipient MRC5 cells, in contrast to mockexposed controls (Fig. 5b ). These transcripts, including (CATTC)n, (GAATG)n and HSAT2, were elevated by up to 10-fold in EV-treated cells compared to controls, while levels of major satellite repeats BSR and MSR1 were not changed (Extended Data Fig. 10a ). In contrast to TC32 EVs in which sense and antisense transcripts were equally represented, in MRC5 cells they were found predominantly in the sense orientation (Jaccard coeff. ~0.05; Extended Data Fig. 10b ), pointing to their strand-specific accumulation or de-novo transcription. Among other upregulated repeat RNAs, we identified LINE/RTE-X, LTR/ERV-L and SINE-Alu (Extended Data Fig. 10c ), although their functional significance remains to be determined.
Strand-specific accumulation of pericentromeric transcripts in MRC5 cells prompted us to examine their potential amplification, which could be driven by Pol II 29, 31, 32 or by RTs of either cellular (such as TERT, shown for HSAT2 40 ) or retroviral 41, 42 origin. We found that Pol II inhibitor DRB and, to a lesser extent, actinomycin D (ActD; a pleiotropic polymerase inhibitor) strongly blocked accumulation of HSAT2, ACRO1 and HERV-Kenv, along with IFNβ mRNA used as an internal control (Fig. 5c ). The RT inhibitors 3'-Azido-3'-deoxythymidine (AZT/zidovudine; an inhibitor of HIV, HERV-K and L1-encoded RT activities 42, 43 ) and nevirapine (NVP) had moderate effects, with AZT being more efficient in reducing levels of HSAT2, HERV-Kenv and ACRO1 by ~1.6 and 2.5-fold, respectively ( Fig. 5c ); the observed reduction in IFNβ mRNA levels could be due to a decrease in repeat RNAs and diminished antiviral response under these conditions. Neither treatment affected levels of 18S rRNA, indicating specificity and supporting the involvement of Pol II-and, potentially, RT-dependent mechanisms into propagation of EwS EV-derived RNAs in recipient cells. Furthermore, recipient MRC5 cells were also capable of releasing HSAT2 and ACRO1 in their own EVs and transferring them to freshly plated MRC5 cells.
Strikingly, even after a third transfer, HSAT2 levels were significantly higher than those in EVs from mock-treated MRC5 cells (p<0.05; t-test; Fig. 5d ), indicating that "infected" fibroblasts are capable of amplifying and further disseminating EwS-derived transcripts.
Further analysis of RNAseq data revealed that in addition to repeat RNAs, there were small but intriguing changes in coding transcripts. Among 109 mRNAs downregulated in TC32 EV-treated MRC5 cells relative to mock, we identified suppressor of cytokine signaling 2 (SOCS2), transcriptional regulators HES4 and KLF2, proto-oncogene receptor tyrosine kinase KIT and the Notch ligand DLL4 ( Fig. 5e and Extended Data Table 6a ). Among 297 upregulated mRNAs, there were IRF7, IL8, IL32, TNFRSF14 and MB21D1/CGAS ( Fig.5e and Extended Data Table 6b), consistent with the observed activation of antiviral and proinflammatory responses. However, the largest group of upregulated mRNAs (54 of 297) were those encoding centromeric proteins and kinetochore complex assembly components ("CENPA/NDC80" module), key regulators of centrosome maturation, spindle assembly and chromatin condensation ("PLK1/NEK2" module), and other cell division and DNA damage control proteins ("BRCA1/TOP2A" module; Fig.5f and Extended Data Table 6c ), all of which are known to be involved in pericentromeric heterochromatin maintenance 29, 44, 45 . Activation of these pathways may thus be indicative of extensive centromeric heterochromatin remodelling in recipient cells. Collectively, our findings demonstrate transfer of pericentromeric and retroelement RNAs in EwS EVs, their propagation in recipient cells, and further transmission in the recipient cell EVs.
DISCUSSION
Our study shows that global de-repression of constitutive heterochromatin regions, a process that has previously been linked to different stages of development, aging and cancer 26, 29, 31, 32 , may have more far-reaching implications than previously anticipated. In particular, we establish that diverse classes of retroelement and pericentromeric chromatin-derived transcripts including L1, HERV-K, HSAT2 and ACRO1 are not only massively expressed in EwS cell lines and tumors, but are also preferably secreted in EVs and their levels in plasma EVs are associated with inflammation and metastatic progression. Our data provides strong support for the Trojan exosome hypothesis 46 , which postulates that HIV and other retroviruses and LTR (and non-LTR, as shown here) retrotransposons exploit exosomal pathways for their spread, preferentially infecting cells of the immune system. Indeed, we show that EwS EV-derived RNAs are taken up by healthy donor PBMCs, predominantly targeting CD33 + myeloid cells and, to a lesser extent, CD8 + T-cells. Respective HERV-K and HSAT2-positive cell populations were significantly expanded in the peripheral blood of EwS patients compared to healthy donors. These populations exhibited phenotypic features of MDSCs (CD33 + HLA-DR -, CD33 + CD25 + , CD33 + PD1 + ) 11, 33, 37 and of exhausted or regulatory CD8 + T-cells (CD8 + CD25 + PD-1 + ) 13, 35 . EwS-derived RNAs may thus co-opt key cell populations of the innate and adaptive immune system, skewing them towards immunosuppressive phenotypes. This phenomenon may underlie the reported EV-driven generation of MDSCs 6, 9, 11 , and their expansion in blood of patients with aggressive sarcomas including EwS 34 , melanoma and other types of cancer 11 . Induction of these immunosuppressive cells and their ability to produce central mediators of inflammation and tolerance (including IL-10, IL-35, IDO1 and TGFβ detected in patients' blood and in in vitro models used in this study) may further compromise proper differentiation of myeloid cells and lymphocytes, subsequently dampening antitumor immunity.
Improperly differentiated immune cells may also infiltrate or be generated at tumor sites, which could contribute to the observed scarcity of mature DCs and cytotoxic CD8 + T-cells in EwS tumors 16, 17 .
These findings may have implications for a wider range of immunologically cold tumors, given the reported association between high expression of L1, ERVs and HSAT2 and immunosuppression, characterized in part by fewer infiltrating CD8 + T-cells in HSAT2-high colon and pancreatic cancers 47 .
Given the multiple virus-like features of LINEs, SINEs, LTR/ERVs and other repeat-containing
RNAs, such as exposed 5'-triphoshate ends 7 , EV RNA unshielding 24 , pathogen-like motif patterns (i.e., high CpG content in AU-rich contexts as shown for HSAT2 48 ), as well as their ability to generate dsRNAs and/or RNA-DNA intermediates 40,41,49-51 , it is not unexpected that we observed vigorous IFN-driven antiviral responses triggered by EwS EVs in the recipient cells, including myeloid progenitors and fibroblasts. Because of the high abundance of hundreds of thousands of such species detected in EwS EVs in this study and in other cancers 7, 52 , this may be a ubiquitous process which is not restricted to particular retroelement species. Most likely, these species act as a broad population with a common action, each of which is capable of triggering innate responses in a wide range of host cells. Their synergistic effect may create a permissive tumor environment both locally and systemically. This does not exclude, however, that some of them, including HERV-K and HSAT2, may have more specialized functions, such as selective targeting of immature myeloid cells and CD8 + T-cells to induce immunosuppressive phenotypes.
Another unexpected finding of this study is that despite their obvious lack of coding or replicative potential, some of these transcripts, including HSAT2 and ACRO1, are further propagated in recipient MRC5 fibroblasts and then released in their respective EVs, being capable of "infecting" freshly plated cells. They seemingly exploit cellular machinery of recipient cells for their own propagation, packaging and further disseminating in recipient cell EVs. Although the exact mechanism remains to be determined, our data indicates that it can be mediated by Pol II, based on the efficient blockade of retroelement RNA accumulation in recipient cells by the RNA Pol II inhibitor DRB. One possibility is that these RNAs recognize and remodel the respective heterochromatin regions to activate transcription. This is supported by the observed upregulation of mRNAs whose protein products are responsible for pericentromeric chromatin maintenance as well as by multiple reports showing that pericentromeric chromatin transcription is Pol II-dependent and regulated by pericentromeric transcripts and by their ability to recruit chromatin remodelers 29, 31, 32 . Alternatively, retroelement activation in recipient cells could be triggered by antiviral and stress responses known to induce transcription of endogenous retroelements, including HERV-K, L1 and pericentromeric transcripts 29, 31, 32, 41 . Also, we cannot exclude reverse transcription as a potential mechanism, considering that some L1, HERV-K and other LTR/ERVs identified in EwS EVs may encode RT and other retroviral proteins, and because RT inhibitors were moderately effective in blocking accumulation of these transcripts in MRC5 cells. None of these scenarios are mutually exclusive, nor require fully intact L1 or HERV-K, or their reintegration into the genome, as would be expected from canonical models 26, 41, 49, 53 . Further investigation into these mechanisms may provide unique insights into cancer-associated inflammation, evasion of antitumor immunity and immunosuppression, and open novel directions for therapeutic targeting.
METHODS
Plasma EV purification and analysis
Blood plasma specimens were obtained from Ewing sarcoma participants enrolled in GenEwing and NEO-IDENT studies, as well as from non-cancer individuals undergoing routine checkups at the allergy and asthma clinic at the Technical University München. Each cohort received approvals from the respective institutional review boards, Comité de Protection des Personnes, Ile-de-France (#09-12037) and the Ethikkommission der Medizinischen Fakultät der Technischen Universität München (#2562/09).
After thawing, plasma (1 ml/patient) was clarified by centrifugation at 10,000 g for 20 min. Supernatants were passed through 0.22 μm filters, diluted with an equal volume of ice-cold phosphate buffered saline (PBS) and centrifuged at 100,000 g (S110-AT rotor, Thermo Scientific), 4 o C for 120 min. Pellets were re-suspended in 3 ml of PBS and pelleted again by ultracentrifugation, to remove plasma contaminants.
Purified EVs were either directly used for RNA isolation or dissolved in 300 μl PBS and used for immunoblotting (see Extended Data Table 7 for antibodies used) or Nanoparticle Tracking Analysis (NS300 NTA; NanoSight). Respective protocols for clinical sample handling and processing were reviewed and approved by the University of Toronto ethics committee (#35129).
EV purification from cell cultures and functional assays
Cell line sources and growth conditions are listed in Extended Data Table 8 . For EV purification, EwS cell lines were grown on four 15-cm plates up to ~80% confluency in 10% fetal bovine serum (FBS) medium, treated with 0.5 mM sodium arsenite (SA) for 30 min or PBS, and then the medium was replaced with fresh one containing 2% EV-depleted FBS (System Biosciences). Conditioned medium (CM) was collected after overnight incubation and subjected to sequential centrifugation at 1,500 g for 10 min and 10,000 g for 20 min, to remove cell debris and larger particles. CM was then concentrated using the Amicon Ultra-15mL-30K tubes (Millipore), passed through 0.22 μm filters, diluted with equal volumes of PBS and subjected to ultracentrifugation at 100,000 g for 120 min. To remove contaminating proteins, EV pellets were then re-suspended in 3 ml of PBS and pelleted again by ultracentrifugation.
Purified EVs were dissolved in 500 μl PBS and used for functional testing.
Treatment of MRC5 and HL-60 cells with 50 μl EVs (1x10 9 particles/100,000 cells/well in 24-well plates) or mock isolates prepared from the equal volume of 2% FBS non-conditioned growth medium was carried out in 500 μl of the appropriate 2% FBS growth medium for 6 h, in duplicate. Cells and CM were collected after 18 or 24 h incubation in a fresh medium, as indicated in figure legends. Where indicated, polymerase (ActD, #A1410 and DRB, # D1916, Sigma) or reverse transcriptase (AZT, #A2169 and NVP, #SML0097, Sigma) inhibitors were added for the last 8 h of 24-h incubation of MRC5 cells with mock or TC32 EVs. Cell-to-cell transfer was assayed in the same 24-well format (12 wells/condition), by applying EVs isolated from CM onto freshly plated MRC5 cells for 6 h and collecting CM 24 h later. Due to low EV yields from mock-treated MRC5 cells, double amounts of cells were used for their purification. After optimizing conditions, each experiment was repeated at least three times.
Bio-Plex proinflammatory protein profiling
Proinflammatory protein profiling of blood plasma (12 μl/reaction) or CM from the cell lines (50 μl/reaction) was done using the magnetic bead-based multiplex immunoassay Bio-Plex 200 system and the 37-plex human inflammation panel (171AL001M, Bio-Rad) following manufacturer's recommendations. Each CM sample was prepared in duplicate and experiments were repeated at least three times using different EV preparations. Plasma proinflammatory protein profiles were generated from three independent measurements of the same specimens. Standard and sample cytokine concentrations were then calculated using the Bio-Rad Bio-Plex 200 software. Background corrected signals for each cytokine were normalized to the mean signal intensity obtained for each sample and were plotted using the mean and standard deviation from three independent experiments.
MUTZ-3 differentiation and EV treatment
Immature and mature MUTZ-3 DCs were generated as described 36 . Briefly, MUTZ-3 were cultured in MEMα growth medium (12571-063, ThermoFisher) containing 20% FBS and 40 ng/ml GM-CSF (PHC2015, ThermoFisher). To generate immature DCs (iDCs), MUTZ-3 cells were incubated for 7 days in a 6-well plate (1.5x10 6 cells/well) in 2 ml of growth medium supplemented with 100 ng/ml GM-CSF, 20 ng/ml IL-4 (P05112, R&D Systems) and 2.5 ng/ml TNFα (P01375, R&D Systems) in the presence or absence of TC32 EVs (100 µl/2x10 9 particles/well) for the first 3 days of incubation. Maturation was induced by adding a cytokine cocktail consisting of 50 ng/ml TNFα, 100 ng/ml IL-6 (Q75MH2, R&D Systems), 25 ng/ml IL-1β (NP000567, R&D Systems) for the additional 3 days. Treatment of healthy donor PBMCs (2x10 6 cells/well in 12-well plates, in duplicates) with 100 μl EVs (2x10 9 particles/well) was carried out in 1 ml of RPMI-1640, 10% FBS growth medium for 48 h, and then cells were processed for staining using the PrimeFlow RNA kit (#8818005204; ThermoFisher). Staining was done according to the manufacturer's instructions, stepwise, using cell viability dye (FVD EF506), fluorescently-labeled antibodies against the respective cell surface markers and, finally, RNA probes for HERV-K AF647 (Type 1) and HSAT2 AF750 (Type 6). Positive control probe RPL13a AF647 (Type 1) was used for optimization; see Extended Data Table 7 and probe sets designed to specifically hybridize to human HERV-Kpol (VF1-18759-06) and HSAT2 (VA6-19493-06), and mouse S100a4/Fsp-1 (VB1-18990-06) and Ptprc/Cd45 (VB1-12657-06) RNAs, in accordance with the manufacturer's instructions. Briefly, 5 μm FFPE sections were baked and deparaffinised, followed by heat pretreatment and protease digestion. Target probes were then hybridized for 2 h at 40°C followed by ViewRNA signal amplification. Signal detection was performed sequentially, using Fast Blue and Fast Red substrates, and slides were then counterstained with hematoxylin. Signal was considered specific if normal kidney tissue and non-probe controls stained in parallel showed less than 1 dot per 20 cells. Regions of interest were captured at x100 magnification using a Leica DM2000LED microscope and LAS software with a pixel resolution of 0.04 μm/pixel. Stain separation of the fast blue, fast red and nonspecific background signals were achieved using a python implementation of the independent component analysis approach 54 . The resulting deconvoluted images were analysed using a custom rule set built in the object-oriented machine learning software Developer XD (Definiens AG, Munich, Germany). The rule set first separated nuclear regions from nonspecific signal using a weighted combination of all isolated stain intensities, with watershed and object reshaping algorithms being employed to identify and separate closely-spaced nuclei. Blue and red spots were then detected with the fast blue and fast red channels, respectively. The resulting cell objects were exported as a table listing the number and type of spots within each cell. The number of cells containing at least one red spot, one blue spot, or both were tabulated as a fraction of total cells detected.
PBMCs treatment, PrimeFlow RNA assay and flow cytometry
RNA extraction and whole transcriptome RNAseq
Total RNAs from EwS cell lines and the respective EVs, and plasma EVs were purified using the mirVana RNA isolation kit (AM1561, ThermoFisher), treated with Turbo DNase (AM1907, ThermoFisher) and quantified using the Qubit RNA high sensitivity kit (Q32852, ThermoFisher). RNA integrity was analyzed with the RNA 6000 Pico or Small RNA chips (Agilent Technologies), and preparations of the sufficient quantity and quality were then used to construct strand-specific RNAseq libraries with the TruSeq Stranded Total RNA library prep and RiboZero rRNA removal kit (20020596, Illumina). Libraries were pooled in sets of 4 and sequenced using the HiSeq PE cluster kit v4 on the Illumina HiSeq 2500 sequencer.
Reverse transcription (RT), quantitative (qPCR) and droplet-based digital PCR (ddPCR)
cDNA was synthesized using SuperScript III Reverse Transcriptase (18080044, ThermoFisher), 0.5 μg of DNase-treated RNA and random hexamer primers. Negative control RNA samples were pretreated with a mixture of RNase A and T1, to control for genomic DNA contamination. One μl cDNA (of total 20 μl) was used for PCR with the respective primer sets (Extended Data Table 9 ) and Q5 High-Fidelity 2X
Master Mix (M0492S, NEB). PCR reactions were incubated at 94 o C for 1 min followed by 4 cycles of 
Bioinformatics and statistical analysis
Paired-end strand-specific 100 or 125-bp reads were aligned to human genome build 37 (hg19/GRCh37) using the BWA aligner v.0.7.13 with subsequent filtering of ribosomal and tRNA reads, followed by removal of secondary alignments and reads with mapping score less than 30. Transcript expression was quantified as the numbers of fragments per million (FPM). Based on annotations from the Known Genes track of UCSC browser, reads were assigned to different transcript classes using bedtools suite . 2d, e and Extended Data Fig. 2b-d 
